Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,451 | -43,689 | -28,083 | -13,199 | -34,380 |
| Depreciation Amortization | 5,082 | 4,053 | 2,641 | 1,249 | 4,647 |
| Accounts receivable | -260 | 53 | 52 | -82 | 7 |
| Accounts payable and accrued liabilities | -1,270 | -1,911 | -2,266 | 1,631 | -3,510 |
| Other Working Capital | -5,878 | -10,293 | -7,809 | -4,382 | -1,207 |
| Other Operating Activity | 9,553 | 7,244 | 5,332 | 93 | 10,504 |
| Operating Cash Flow | $-47,223 | $-44,543 | $-30,134 | $-14,691 | $-23,939 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -6,014 | -9,970 | 18,686 | 1,492 | -40,726 |
| PPE Investments | -1,421 | -712 | -514 | -135 | -7,918 |
| Investing Cash Flow | $-7,435 | $-10,682 | $18,173 | $1,357 | $-48,644 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -209 | -155 | -102 | -198 | -198 |
| Common Stock Issued | 60,216 | 58,592 | 57,085 | 224 | 12,692 |
| Other Financing Activity | -55 | -55 | -55 | 0 | -439 |
| Financing Cash Flow | $59,953 | $58,382 | $56,928 | $26 | $12,055 |
| Beginning Cash Position | 24,839 | 24,839 | 24,839 | 24,839 | 85,367 |
| End Cash Position | 30,133 | 27,995 | 69,805 | 11,531 | 24,839 |
| Net Cash Flow | $5,295 | $3,157 | $44,967 | $-13,307 | $-60,528 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,223 | -44,543 | -30,134 | -14,691 | -23,939 |
| Capital Expenditure | -1,421 | -712 | -514 | -135 | -7,918 |
| Free Cash Flow | -48,645 | -45,255 | -30,648 | -14,826 | -31,857 |